Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 205,591,101 papers from all fields of science
Search
Sign In
Create Free Account
Oxybutynin chloride 5 MG Oral Tablet
Known as:
OXYBUTYNIN CHLORIDE 5 mg ORAL TABLET [Oxybutynin Chloride]
, OXYBUTYNIN CL 5MG TAB [VA Product]
, OXYBUTYNIN CHLORIDE 5MG TAB UD
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
Broader (2)
ANTISPASMODICS,URINARY
oxybutynin
Aluminum Oxide
Brilliant blue FCF
CALCIUM STEARATE
Drug Allergy
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials
R. Dmochowski
,
V. Nitti
,
D. Staskin
,
K. Luber
,
R. Appell
,
G. Davila
World Journal of Urology
2005
Corpus ID: 8434829
The safety and efficacy of oxybutynin transdermal delivery system (oxybutynin-TDS) versus placebo in adults with urge and mixed…
Expand
2005
2005
In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin.
T. Oki
,
A. Kawashima
,
M. Uchida
,
S. Yamada
Life sciences
2005
Corpus ID: 24434197
2005
2005
267Parenteral oxybutynin: A local anaesthetic effect on bladder C-afferents
K. Laet
,
S. Wachter
,
J. Wyndaele
2005
Corpus ID: 71274243
2004
2004
Demonstration of bladder selective muscarinic receptor binding by intravesical oxybutynin to treat overactive bladder.
T. Oki
,
R. Kimura
,
M. Saito
,
I. Miyagawa
,
S. Yamada
The Journal of urology
2004
Corpus ID: 28069477
PURPOSE The current study was done to elucidate the in vivo mechanism of action of intravesical instillation of oxybutynin to…
Expand
Highly Cited
2003
Highly Cited
2003
Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.
S. de Wachter
,
J. Wyndaele
The Journal of urology
2003
Corpus ID: 8692505
PURPOSE Intravesical oxybutynin is used to control bladder overactivity in patients who are refractory to or cannot tolerate…
Expand
Highly Cited
2002
Highly Cited
2002
Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.
R. Dmochowski
,
G. Davila
,
+4 authors
S. Sanders
The Journal of urology
2002
Corpus ID: 39033241
Highly Cited
2001
Highly Cited
2001
Side‐effects of oral or intravesical oxybutynin chloride in children with spina bifida
P. Ferrara
,
C. D'Aleo
,
E. Tarquini
,
S. Salvatore
,
E. Salvaggio
BJU international
2001
Corpus ID: 42481479
Objective To evaluate the incidence of side‐effects of oral and intravesical oxybutynin chloride in children with…
Expand
Highly Cited
1998
Highly Cited
1998
Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism.
G. Buyse
,
K. Waldeck
,
C. Verpoorten
,
H. Björk
,
P. Casaer
,
K. Andersson
The Journal of urology
1998
Corpus ID: 22031367
Highly Cited
1997
Highly Cited
1997
Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland.
K. Waldeck
,
B. Larsson
,
K. Andersson
The Journal of urology
1997
Corpus ID: 37791289
Highly Cited
1992
Highly Cited
1992
Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers.
K. M. Hughes
,
J. Lang
,
+4 authors
M. Geraint
Xenobiotica; the fate of foreign compounds in…
1992
Corpus ID: 24021052
1. A quantitative h.p.l.c. plasma assay for oxybutynin (OB) and its active metabolite, N-desethyl oxybutynin (DEOB) is described…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE